GSK

GSK
D

GSK

Arincen73/100B

Who owns GSK?

Institutions own 17.3% of GSK's shares, through 1,080 funds, banks and other managers that report their holdings to the SEC; individual investors and others hold the rest. The largest on 30 June 2026 were FMR LLC (3.2%), Dodge & Cox (2.4%), Fisher Asset Management, LLC (1.8%).

Institutions own
17.3%
Institutional holders
1,080
The 10 largest hold
11.1%
Free float
95.8%
Holdings as of
30 Jun 2026

Who owns the shares

10 largest holders 11.1% Other institutions 6.2% Individuals and others 82.7%

Shares free to trade

Free float 1.94B shares ·95.8% Closely held 84.36M shares ·4.2%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

The largest shareholders

#HolderSharesOf the companyValueChange last quarter (shares)
1FMR LLC64,961,6413.24%3.41B USD-2,700,005
2Dodge & Cox48,197,5142.40%2.53B USD-10,465,460
3Fisher Asset Management, LLC35,722,7921.78%1.87B USD+1,200,429
4Primecap Management Co25,182,0681.25%1.32B USD-22,470
5Wellington Management Group LLP11,396,2490.57%597.39M USD-321,364
6Jtc Employer Solutions Trustee Ltd8,592,9870.43%450.32M USD-449,402
7Morgan Stanley7,657,5620.38%401.41M USD-3,373,089
8Royal Bank Of Canada7,588,9280.38%397.81M USD+82,142
9Price T Rowe Associates Inc6,923,6420.35%362.94M USD-399,191
10Acadian Asset Management LLC6,660,4340.33%349.11M USD-5,136,651

All institutions last quarter

Bought or added
604 · 111 new
Sold or cut
445 · 98 sold out
Net shares bought
-27.01M · 1.42B USD
Institutional ownership
18.6% → 17.3%

Biggest buyers last quarter

  • Point72 Asset Management, L.P.+2,652,881
  • JPMorgan Chase & Co+1,506,186
  • Fisher Asset Management, LLC+1,200,429
  • D. E. Shaw & Co., Inc.+1,019,449
  • Thomasville National BankNew position

Biggest sellers last quarter

  • Dodge & Cox-10,465,460
  • Acadian Asset Management LLC-5,136,651
  • Morgan Stanley-3,373,089
  • Goldman Sachs Group Inc-3,217,672
  • FMR LLC-2,700,005

From the holders' 13F filings with the SEC for the quarter to 30 Jun 2026, filed up to 45 days after it; the buyers and sellers are among the 100 largest holders.

Common questions about GSK's shareholders

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.